Weika Mycobacterium Vaccae for Injection Product Leaflet

Product leaflet for Mycobacterium Vaccae for Injection, detailing composition, dosage, indications, and safety information.


Weika Mycobacterium Vaccae for Injection Product Leaflet - cover page
Brand
微卡
Category
Other
Document type
Product Leaflet
Language
Chinese
Pages
9
File format
PDF
File size
374 KB
Published
28 September, 2026
Updated
28 September, 2026
MD5 checksum
1F3846C4E9D22C1773F418B5E887B2A9

About this manual

Mycobacterium Vaccae for Injection (brand 微卡) is a lyophilized white powder that, after reconstitution, becomes a clear liquid. It is indicated for the prevention of pulmonary tuberculosis in adults aged 15‑65 with latent infection and may be used as an adjunct in tuberculosis chemotherapy.

The product is administered by deep intramuscular injection in the gluteal region. The recommended regimen for prevention is one 1 ml vial (containing 22.5 µg protein) every two weeks for a total of six doses. Safety information includes common systemic adverse reactions such as headache, cough, fatigue and irritability, and local pain at the injection site. Contra‑indications, precautions, drug‑interaction warnings and storage conditions are also provided. This manual is written in Chinese.

What's inside

  • Product Name
  • Composition
  • Physical Form
  • Indications
  • Dosage and Administration
  • Contraindications
  • Adverse Reactions
  • Precautions
  • Drug Interactions
  • Storage and Shelf Life

Specifications

Dosage per vial1.0 ml
Protein content per dose22.5 µg Mycobacterium vaccae protein
Storage temperature2 °C – 8 °C, protected from light
Shelf life24 months
Packaging1 glass ampoule per box

Frequently asked questions

How should the product be stored?

Store the product at 2 °C to 8 °C, protected from light.

Download PDF (374 KB)